Topper Copies

You are the Director of the National Bioethics Commission who is responsible for assessing the ethical feasibility and oversight of a nationwide gene sequencing program. The project named GeneFuture, aims to sequence the DNA of every newborn child and store it in a centralized national database. The objective is to identify genetic predispositions to serious diseases early in life, allowing for preventive treatment and personalized medicine. Over 100,000 babies have already been enrolled in the pilot phase of the program. The government claims that this move is a landmark step in public health advancement. However, collection of newborn genetic data raises significant ethical concerns, particularly around informed consent, which may not fully capture parents' understanding of the long-term risks involved. Once gathered, this sensitive data could be misused for purposes such as surveillance, insurance discrimination, or commercial marketing by third parties. Uncertainty over data ownership - whether it lies with the state, parents, or the individual as they mature - further complicates the issue. The involvement of private tech and pharmaceutical companies heightens fears of commercial exploitation, especially in the absence of clear mechanisms for individuals to withdraw consent or delete their genetic information upon reaching adulthood. (a) What are the ethical issues you perceive in the implementation of the GeneFuture program? (b) Identify the conflicting interests of different stakeholders in this case. (c) What guiding ethical principles would you recommend for implementation of this project?

Monika Srivastava, AIR 16, 2025

(a) Ethical issues involved in GeneFuture Program

The above use case highlights importance of ethics in applications of Biotechnology. Lack of clear guidelines might aggravate the issue and can create competing interests causing crisis of conscience for stakeholders

1. Lack of Informed consent for newborn 2. Inadequate Bioethics literacy among parents for long-term impact hinders rational decision making 3. Using Genetic Information to achieve good objectives and Better medical outcomes → Personalised medicine, Preventive Treatment (utilitarianism) 4. Stand by Government → landmark step shows lack of Objectivity in decision making 5. Commercial Exploitation of Genetic Information hurts human dignity (kantian ethics) 6. Duty of Government to protect personal data under Digital Data Protection Act 2023 7. Lack of clarity on future withdrawals → lack of autonomy upon reaching adulthood → lack of data sovereignty with Public 8. Violation of Science for Humanity → A sin by Gandhiji

(b) Conflicting interests of stakeholders

Different stakeholders → 1 Director of Commission, 2 NewBorn child, 3 Parents of child, 4 private sector, 5 Regulatory Bodies like Department of Biotechnology, 6 Society, media

1. Director: Completion of Gene sequencing program → Assessment of feasibility 2. New Born Child → Right to Privacy → control over own data on reaching adulthood 3. Parents → Taking decision on behalf of Child for his Benefit → limited Knowledge to take decision 4. Private sector → corporate Social Responsibility → Profit making using right process and purpose 5. Department of Biotechnology → provide regulatory framework → Balance competing interests → Achieve maximum utility by minimising harm

(c) Guiding ethical principles for project implementation

1. Information Sharing with parents regarding long term effects of data sharing 2. Fulfilling duty of director to balance Science with humanity 3. Rule formulation for future course of action if adult wants to withdraw 4. Transparency and accountability in storing personal data 5. Collecting minimal data and maintaining accuracy of data eg using Blockchain for storage 6. Robust cyber security measures to avoid data breach 7. Clear ownership rules of data (consent ownership with Parents and after 18 years with Adult) 8. Deter using data for profit making and only for medical Purpose

Science without humanity is a sin, hence principles of Bioethics like No Harm, Maximum Benefit, Informed consent and Free will should be followed to uphold data Integrity.